Exact Mass: 598.1391

Exact Mass Matches: 598.1391

Found 23 metabolites which its exact mass value is equals to given mass value 598.1391, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Yunnaneic acid F

(+)-Yunnaneic acid F

C29H26O14 (598.1322)

3,3,4,5,9,10-hexahydroxy-12-methylchroman[2,3-h]flavone 3-O-beta-D-glucopyranoside|lactucasativoside A

C29H26O14 (598.1322)

3-methoxy-7-O-beta-(6-galloylglucopyranoside)kaempferol

C29H26O14 (598.1322)

KN-93 Phosphate

C26H32ClN2O8PS (598.1305)

1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ide,dichloro(3-pyridin-2-ylpropylidene)ruthenium

C29H36Cl2N3Ru (598.133)

(s)-(+)-1,1-bi-2-naphthyl di-p-toluenesulfonate

C34H30O6S2 (598.1484)

N-[(1S)-1-[[(6S)-6-[5-(7-BROMO-9,9-DIFLUORO-9H-FLUOREN-2-YL)-1H-IMIDAZOL-2-YL]-5-AZASPIRO[2.4]HEPT-5-YL]CARBONYL]-2-METHYLPROPYL]CARBAMIC ACID METHYL ESTER

C29H29BrF2N4O3 (598.1391)

(R)-(-)-2,2-Bis(p-toluenesulfonyloxy)-1,1-binaphthalene

C34H30O6S2 (598.1484)

IACS-010759 (hydrochloride)

C25H26ClF3N6O4S (598.1377)

IACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 hydrochloride has the potential for relapsed/refractory AML and solid tumors research[1][2].

13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

6-[(3,4-dihydroxy-2-methoxyphenyl)methyl]-7-(3,4-dihydroxyphenyl)-2,10-dihydroxy-9,11-dimethoxy-5-oxatetraphen-3-one

C33H26O11 (598.1475)

(1r,2s,6s,7r,8r,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

(1r,2s,6s,7r,8r,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

(13s)-13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

10-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

(13r)-13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone

C33H26O11 (598.1475)

2-{[5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 3,4,5-trihydroxybenzoate

C29H26O14 (598.1322)

2-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl 3,5-dihydroxy-4-methoxybenzoate

C29H26O14 (598.1322)

(2s,3r,4r,5s,6s)-2-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl 3,5-dihydroxy-4-methoxybenzoate

C29H26O14 (598.1322)

(1r,2s,6s,7r,8s,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

(1r,2s,6s,7r,8s,9r)-10-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-8-(3,4-dihydroxyphenyl)-2,6-dihydroxy-4-oxo-3-oxatricyclo[5.2.2.0²,⁶]undec-10-ene-9-carboxylic acid

C29H26O14 (598.1322)

6-[(3,4-dihydroxy-2-methoxyphenyl)methyl]-8-(3,4-dihydroxyphenyl)-2,10-dihydroxy-9,11-dimethoxy-5-oxatetraphen-3-one

C33H26O11 (598.1475)